| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Oculis Holding AG | Privosegtor - (PIONEER-1) | Acute Optic Neuritis (AON) | Phase 3 | Trial Planned | oral | Opthalmic |
| Oculis Holding AG | Licaminlimab (OCS-02) - (PREDICT-1) | Dry eye disease | Phase 3 | Trial Planned | Topical ocular | Opthalmic |
| Oculis Holding AG | OCS-01 - (DIAMOND-1) | Diabetic macular edema (DME) | Phase 2/3 | Ongoing | Topical ophthalmic | Opthalmic |
| Oculis Holding AG | OCS-02 | Uveitis | Phase 2b | Trial Planned | Topical | Opthalmic |
| Oculis Holding AG | OCS-05 - (ACUITY) | Acute optic neuritis | Phase 2 | Data Released | Intravenous | Opthalmic |
| Oculis Holding AG | OCS-01 - (LEOPARD) | Cystoid macular edema | Phase 2 | Ongoing | Ocular | Opthalmic |
| OKYO Pharma Limited | urcosimod (OK-101) | Dry Eye Disease (DED) | Phase 2 | Data Released | Ocular | Opthalmic |
| OKYO Pharma Limited | Urcosimod (OK-101) | Neuropathic corneal pain (NCP) | Phase 2a | Data Released | Ocular | Opthalmic |